Controlled stimulation delivery from neurostimulator

Patent metadata

Field	Value
Publication number	US-11464989-B2
Application number	US-201916515460-A
Country	US
Kind code	B2
Filing date	Jul 18, 2019
Priority date	Nov 13, 2011
Publication date	Oct 11, 2022
Grant date	Oct 11, 2022

Abstract

A system for providing neurostimulation includes an external device (“external exciter”) and an implanted device. The external exciter includes an energy source which inductively powers the implanted device. Examples of such external exciters include devices having at least one of: ultrasonic transducers, Radio Frequency (RF) transmitters, and solar cells. The implanted device includes circuitry that limits its maximum energy output to a predetermined saturation threshold such that excess stimulation from the external exciter does not raise the output of the implanted device beyond the saturation threshold. The output signal of the external exciter is then pulse-width modulated in order to produce a desired amount of output stimulation from the implanted device to stimulate the bioelectrically excitable tissue at a desired level.

First claim

The invention claimed is:

1. A neurostimulation system for stimulating tissue, the system comprising:
an implantable device, the implantable device comprising:
an energy acquisition device configured to wirelessly receive an excitation signal and including a device selected from the group consisting of a piezoelectric element configured to wirelessly receive the excitation signal, a dipole antenna configured to wirelessly receive the excitation signal, and a solar cell configured to wirelessly receive the excitation signal;
an electrode configured to deliver an electric current to the tissue, the electric current being powered directly by the excitation signal; and
a rectifier connected to the energy acquisition device and configured to rectify an AC electric current, received from the energy acquisition device, to a DC electric current.

2. The neurostimulation system of claim 1 , further comprising an exciter configured to radiate the excitation signal as a pulse width modulated excitation signal to the energy acquisition device.

3. The neurostimulation system of claim 2 , wherein the implantable device further comprises
a voltage-limiting device, directly connected to the rectifier,
wherein the rectifier is directly connected to the energy acquisition device, and
wherein the electrode is directly connected to the voltage-limiting device.

4. The neurostimulation system of claim 3 , wherein the rectifier includes a Schottky diode.

5. The neurostimulation system of claim 3 , wherein a pulse of the pulse width modulated excitation signal has an amplitude sufficient to cause the implantable device to operate in a voltage saturation mode.

6. The neurostimulation system of claim 2 ,
wherein the energy acquisition device is configured to convert the excitation signal into the AC electric current, and
wherein the electrode is configured to deliver at least a portion of the DC electric current to the tissue.

7. The neurostimulation system of claim 1 ,
wherein the implantable device is capable of fitting within a lumen of a hypodermic needle.

8. The neurostimulation system of claim 7 , further comprising an exciter configured to radiate the excitation signal as a pulse width modulated excitation signal to the energy acquisition device.

9. The neurostimulation system of claim 8 , wherein the implantable device has a length of at least 1 cm and at most 2 cm.

10. The neurostimulation system of claim 8 , wherein the implantable device further comprises
a voltage-limiting device configured to limit an amount of energy delivered to the tissue.

11. The neurostimulation system of claim 10 , wherein the rectifier includes a Schottky diode.

12. The neurostimulation system of claim 8 , wherein:
the electrode is a first electrode,
the implantable device further comprises a second electrode configured to deliver an electric current to the tissue,
the first electrode is at a first end of the implantable device, and
the second electrode is at a second end of the implantable device.

13. The neurostimulation system of claim 1 , wherein the implantable device is configured so that power received at the energy acquisition device from the excitation signal is provided immediately to the electrode.

14. The neurostimulation system of claim 1 , wherein the excitation signal includes an ultrasound signal, and
wherein the energy acquisition device includes a piezoelectric element including a piezoelectric material and configured, when the implantable device is implanted within the tissue, for the piezoelectric material to wirelessly receive the ultrasound signal from the tissue and for the piezoelectric material to generate a voltage when the ultrasound signal is wirelessly received by the piezoelectric material.

15. The neurostimulation system of claim 1 , wherein the energy acquisition device includes a dipole antenna configured to wirelessly receive the excitation signal.

16. The neurostimulation system of claim 1 , wherein the energy acquisition device includes a solar cell configured to wirelessly receive the excitation signal.

17. A neurostimulation system for stimulating tissue, the system comprising:
an implantable device, the implantable device comprising:
an energy acquisition device configured to wirelessly receive an excitation signal;
an electrode configured to deliver an electric current to the tissue, the electric current being powered directly by the excitation signal; and
a rectifier connected to the energy acquisition device and configured to rectify an AC electric current, received from the energy acquisition device, to a DC electric current,

wherein the implantable device is configured, upon receipt of the excitation signal having power in a first harmonic, to re-radiate a portion of the received excitation signal in a re-radiated signal having power in an nth harmonic, n being an integer greater than 1.

18. The neurostimulation system of claim 17 , further comprising an exciter configured to radiate the excitation signal to the energy acquisition device.

19. The neurostimulation system of claim 18 , wherein the excitation signal is a pulse width modulated signal.

20. The neurostimulation system of claim 18 , further comprising a receiver configured to detect the nth harmonic of the re-radiated signal.

21. The neurostimulation system of claim 20 , wherein the nth harmonic is the second harmonic.

22. A method for performing neurostimulation of the tissue of a subject using the neurostimulation system of claim 20 , the method comprising:
radiating, by the exciter, the excitation signal to the energy acquisition device;
detecting, by the receiver, the nth harmonic of the re-radiated signal; and
increasing the power of the excitation signal until an amplitude of the detected nth harmonic no longer increases.

23. The neurostimulation system of claim 18 , wherein the implantable device further comprises
a voltage-limiting device configured to limit an amount of energy delivered to the tissue, and
wherein the rectifier includes a Schottky diode.

24. A neurostimulation system for stimulating tissue, the system comprising:
an implantable device, the implantable device comprising:
an energy acquisition device configured to wirelessly receive an excitation signal;
an electrode configured to deliver an electric current to the tissue, the electric current being powered directly by the excitation signal; and
a rectifier connected to the energy acquisition device and configured to rectify an AC electric current, received from the energy acquisition device, to a DC electric current; and

an exciter configured to radiate the excitation signal as a pulse width modulated excitation signal to the energy acquisition device, a pulse of the pulse width modulated excitation signal having an amplitude sufficient to cause the implantable device to operate in a voltage saturation mode in which the power output by the implantable device in response to the pulse width modulated excitation signal is the same as the power that would be output by the implantable device in response to a higher-power pulse width modulation excitation signal.

Assignees

• Univ Arizona State

Inventors

• Towe Bruce C
• Gulick Daniel

Classifications

• A61N1/37205

  Microstimulators, e.g. implantable through a cannula · CPC title

• A61N1/36175

  Pulse width or duty cycle · CPC title

• A61N5/045

  specially adapted for treatment inside the body · CPC title

• A61N1/3787 Primary

  from an external energy source · CPC title

• A61N1/36125

  Details of circuitry or electric components · CPC title